Member Info for sir_digby

They've already designated a new variant in south America, b1.6. Inevitable considering the number of immunosuppressed individuals in the population it's mostly spreading in.

They've already bought shares, had no lasting impact. They need to spend some of the cash pile instead of just talking a big game. If it's going to take 2 to 3 years to progress through the courts then they need to put it to work, if they lose the case in 3 years time then that's a problem for another day , at least we'll still be around unlike many of those who got contracts, shafted the government and disappeared into the ether.

@ kaeren, that transcript between randox and the government is a disgrace but it seems fair game when you've got a Tory mp on the board. No tests, no machines and no facilities, all in a day's work.

This goes some way to explaining how a previously largely zoonotic disease managed to get a foothold so easily outside of the endemic countries. 50k global cases in > 110 countries will be surpassed by Monday, however, considering Brazil already has an additional 4.9k probables we're already there. This is down to a paucity of testing and a failure of containment, tracing and isolation.

https://t.co/F4PsRGUQ27

Mr Brian, what's their debt situation? Around £800m?

@pl100, of course aim is a cesspool. Here's one for the rogues gallery - langbar international, absolutely hilarious in hindsight and the CEO needed close protection services for quite some time as he got serious and credible death threats. Deservedly many would say.

@drb83 don't we also own our properties? - if so worthless.

No harchris and I don't know a single company on the LSE that's trading at anywhere near the discount this is to it's cash position, nowhere close. Homework for the weekend, I'll try to find one.

Drb, we don't even see them once a year, they've swerved the last 3 AGM in favour of a glorified webcast.

Aye well, TUI for me to the States next week £280 return. No fancy Dan Air France this time round, literally less than half the price for the same sh@t economy seat. If anyone's interested TUI have flights flying to Florida for less than £200 return (+ the usual rip off add ons) from the likes of Manchester next month.

I think they thought it was going to be sorted by Apr/May, explains the directors buys in March. It's going to be uncomfortable for Crinneli because I'll assume Sylvie Dougat bought on his recommendation/nod, am I right in thinking she's his PA or similar.

Something obviously went awry around May, perhaps as simple as NCYT being unwilling to settle for a lesser amount than what was owed leaving the DHSC with no option but to either pay the outstanding invoices or challenge the entire contract. Both assays supplied under the contract have subsequently been accredited by UKHSA so that's one avenue they can't take us down. They (the board)have a fiduciary duty to recover as much from debtors as possible on our behalf so whilst I'm sure we'd all love this to be put to bed (I know I would) with a cheap settlement and no court time it may not be an option.

Even after the dispute was raised there was a subsequent £4m contract and the DHSC has continued to buy our covid assays until at least June 2022 as we've seen the invoices supporting this from a number of NHS trusts.

That's the problem with NDAs, everyone is left second guessing. Question is, is it in either Parties interest to go to court? Literally everything will have to be publicly disclosed, including communications from ministers.

If the company had been suspected of 'ripping off' the public purse, there'd have been no further contracts and the NDA would have gone out of the window long ago so the government could hammer us in the media and cover their own @rses.

There still hasn't been a ruling on the judicial review surrounding the abdx contract brought by the GLP. Perhaps that will have a bearing on it.

There's no debt to discount diickheadz, they have no debt.

@harchris, what infuriates me is that the cash isn't ring fenced in any way in the accounts. They are clearly of the opinion they have a strong case but 20 months later and having decimated the sp through inaction they are still unwilling to utilize any of it. Get it spent you woeful clowns or front up to shareholders why you won't.

Well it's certainly been a circle jerk of negativity today and now we have the directors accused of feeding information to insiders or infact taking out shorts themselves. Both acts would be subject to criminal investigation and no sane minded director would risk doing a serious stint over the wall for such a paltry return, particularly in this sector your reputation would be destroyed. If anyone genuinely thinks this is happening have some balls and post the accusations here or on Twitter in a fashion where you personally can be identified with some evidence to back those claims, even better forward the evidence to the FCA.

Occam's razor should apply here, management have been abysmal and the share price reflects it, no criminality required.

They need to get some m&a done, preferably a US entity to get a foot in the door of what is essentially a closed shop. In short order they need to buy back 10% of the shares and hold them in treasury, don't even bother cancelling them. Their constant failure to do either while talking a big game at AGMs etc is giving the deserved impression that they're a bunch of absolute bluffers.

It's been like watching 2 bald men fighting over a comb.

77 kids in Brazil with MPX including 20 under 4, significantly more than other countries. Cases now in over half the world's nations, 94 non endemic and 11 endemic.

https://t.co/Tuj183hUOH

It's criminal barristers going on strike , nothing to do with contractual and civi litigation. Their money making grift will be unaffected, money doesn't sleep.

They'll get even more breakthrough cases when they start splitting the doses fivefold because they've ran out of vaccine.

Old clinical data showed around 85% efficacy against MPX, the unknown will be how much that has been impacted by the recent mutations that have given it a human to human transmission advantage compared to when those clinical trials took place.

Well it's going to devastate you when you realize their market cap is over 4 times ours, which after all is what matters as a metric.

Well that's the ring vaccination strategy up the swanny. What should use against MPX now, harsh language?

BBC News - Monkeypox: Lack of vaccines sparks pause in UK rollout
https://www.bbc.co.uk/news/uk-62551821

Yeah, best put the tinfoil hat away, the planned shut down was well documented in advance.

Even the manufacturer of jynneos has reservations about the US vaccine splitting strategy. What would they know though, they only make it.

https://twitter.com/ddiamond/status/1557532502453063682?t=8cy8sIo_toPM685oQmXLZQ&s=19

Kaeren, the shut in was pre planned in 2021 apparently to upgrade the facility. It's all well and good for countries to take unilateral action for short term gain but it won't keep the disease out in the long term, do they think people don't travel?

Seems man's best friend can get it as well, from the lancet:

https://t.co/8iZIIe9u8k

Jynneos already had an eua and was being administered in the US, this eua authorizes a fivefold split of the dosage. This will make the current vaccine stock go further but there's concerns that it won't provide long lasting protection because of the significantly reduced dosage. That doesn't help every other country as they can't get any doses at all as production is shut in at the Denmark plant for a couple of months.